We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+3.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.33%
AUM
$12B
AUM Growth
-$353M
(-2.9%)
Cap. Flow
-$617M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
12.46%
Holding
637
New
171
Increased
105
Reduced
150
Closed
191
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delta Air Lines
DAL
|
+$140M |
| 2 |
AbbVie
ABBV
|
+$119M |
| 3 |
KeyCorp
KEY
|
+$115M |
| 4 |
F5
FFIV
|
+$111M |
| 5 |
Walmart Inc
WMT
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$146M |
| 2 |
S&P Global
SPGI
|
+$142M |
| 3 |
Eli Lilly
LLY
|
+$133M |
| 4 |
Labcorp
LH
|
+$131M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.86% |
| 2 | Healthcare | 13.19% |
| 3 | Industrials | 12.91% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Financials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Intercontinental Exchange
ICE
$83.9B
| $11.6M | 0.1% |
+175,742
| New | +$10.8M |
|
227
UnitedHealth
UNH
$378B
| $11.5M | 0.1% |
62,044
-359,476
| -85% | -$63M |
|
|
GTYH
228
CALL
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $11.4M | 0.1% |
+1,133,333
| New | +$11.3M |
|
|
RAD
229
DELISTED
Rite Aid Corporation
RAD
| $10.9M | 0.09% |
184,919
-190,081
| -51% | -$14.4M |
|
230
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $10.9M | 0.09% |
45,000
+15,000
| +50% | +$3.59M |
|
231
Alaska Air
ALK
$5.84B
| $10.8M | 0.09% |
120,017
+93,755
| +357% | +$8.22M |
|
232
JELD-WEN Holding
JELD
$157M
| $10.8M | 0.09% |
+331,241
| New | +$10.7M |
|
|
STRP
233
DELISTED
Straight Path Communications Inc.
STRP
| $10.6M | 0.09% |
+59,169
| New | +$9.02M |
|
|
EGN
234
DELISTED
Energen
EGN
| $10.5M | 0.09% |
+212,292
| New | +$11.3M |
|
|
BSFT
235
DELISTED
BroadSoft, Inc.
BSFT
| $10.5M | 0.09% |
243,418
-211,005
| -46% | -$8.29M |
|
|
NAV
236
DELISTED
Navistar International
NAV
| $10.5M | 0.09% |
+399,130
| New | +$10.5M |
|
237
Trinity Industries
TRN
$2.57B
| $10.2M | 0.09% |
+506,766
| New | +$9.73M |
|
|
ASAP
238
CALL
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $10.1M | 0.08% |
50,000
| – | – |
|
|
ASAP
239
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $10.1M | 0.08% |
50,000
| – | – |
|
|
DERM
240
DELISTED
Dermira, Inc.
DERM
| $10M | 0.08% |
344,789
+118,339
| +52% | +$3.6M |
|
|
ABMD
241
DELISTED
Abiomed Inc
ABMD
| $9.87M | 0.08% |
68,894
-11,106
| -14% | -$1.49M |
|
242
Snap
SNAP
$8.82B
| $9.77M | 0.08% |
550,000
+50,000
| +10% | +$1.01M |
|
243
Heron Therapeutics
HRTX
$96.1M
| $9.55M | 0.08% |
689,397
-106,934
| -13% | -$1.55M |
|
244
Plexus
PLXS
$7.37B
| $9.51M | 0.08% |
180,879
-185,420
| -51% | -$9.83M |
|
|
BLVD
245
CALL
DELISTED
Boulevard Acquisition Corp. II Class A Common Stock
BLVD
| $9.47M | 0.08% |
945,134
| – | – |
|
246
Calix
CALX
$2.4B
| $9.34M | 0.08% |
1,362,820
-1,137,171
| -45% | -$7.71M |
|
247
Carlyle Secured Lending
CGBD
$714M
| $9.19M | 0.08% |
+510,100
| New | +$9.32M |
|
248
Capital One
COF
$136B
| $8.95M | 0.07% |
108,292
-335,969
| -76% | -$27.3M |
|
249
Broadcom
AVGO
$2T
| $8.75M | 0.07% |
+375,460
| New | +$8.71M |
|
|
CMBT
250
CMB.TECH NV
CMBT
$4.65B
| $8.75M | 0.07% |
1,107,207
-644,330
| -37% | -$4.97M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2017 Portfolio in Review
As of Q2 2017, Alyeska Investment Group held 637 positions worth $12B, down 2.9% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Alyeska Investment Group withdrew a net $617M in Q2 2017, closing 191 positions and reducing 150 holdings. Its most notable exit was Eli Lilly, an estimated $133M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Alyeska Investment Group opened a new position in AbbVie worth $128M.
- Alyeska Investment Group's largest Q2 2017 buy was AbbVie: 1,771,895 shares worth $128M.
- Alyeska Investment Group added most to Delta Air Lines in Q2 2017, an estimated $140M increase.
- Alyeska Investment Group's biggest Q2 2017 reduction was Oracle, cutting an estimated $146M.
- Alyeska Investment Group fully exited Eli Lilly in Q2 2017, selling an estimated $133M.
- Alyeska Investment Group's ten largest holdings make up 12% of its $12B portfolio in Q2 2017.
- Alyeska Investment Group opened 171 new positions and closed 191 in Q2 2017.
- Alyeska Investment Group's portfolio value fell 2.9% quarter-over-quarter to $12B.
Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.